$159.81 +0.24 (%) Amgen Inc - NASDAQ

Jan. 23, 2015 | 04:00 PM

Partner Headlines

  1. New Guru Jana Partners' Newest Stock Buys

    GuruFocus | Jan. 22, 2015 | 21:05PM EST
  2. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  3. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  4. Amgen's Decline May Be Linked To Comments Of Express Script's CEO

    Benzinga | Jan. 13, 2015 | 13:18PM EST
  5. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  6. Regeneron rises on drug data

    IBD | Jan. 9, 2015 | 18:42PM EST
  7. Crude Awakening As Energy Squeezes Overall Q4 Profit

    IBD | Jan. 9, 2015 | 17:58PM EST
  8. Regeneron Jumps On Favorable Cholesterol Drug Report

    IBD | Jan. 9, 2015 | 15:42PM EST
  9. Drugs May Be Blockbusters

    IBD | Jan. 8, 2015 | 18:54PM EST
  10. Weekly Review Shows Five Industries Gain In December

    IBD | Jan. 8, 2015 | 18:06PM EST
  11. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  12. Pharmaceutical Companies Amgen and Kite Partner for Cancer Therapy

    GuruFocus | Jan. 7, 2015 | 13:18PM EST
  13. Kite Pharma Gets Stock Price Increase Post Amgen Deal

    IBD | Jan. 6, 2015 | 15:07PM EST
  14. UPDATE: Barclays Initiates Coverage On Amgen

    Benzinga | Jan. 6, 2015 | 12:07PM EST
  15. Amgen, Kite Reach Cell Deal

    IBD | Jan. 5, 2015 | 18:44PM EST
  16. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD | Jan. 5, 2015 | 18:20PM EST
  17. Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, Downgrades

    Benzinga | Jan. 5, 2015 | 15:57PM EST
  18. Kite Pharma Up On Amgen Cancer Parternship

    IBD | Jan. 5, 2015 | 11:49AM EST
  19. Stocks Drop 1% In Rising Volume; Visa Falls 1%

    IBD | Jan. 5, 2015 | 10:33AM EST
  20. Morning Market Losers

    Benzinga | Jan. 5, 2015 | 09:57AM EST
  21. Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm Cell Therapeutics And More

    Benzinga | Jan. 5, 2015 | 09:31AM EST
  22. Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies

    Benzinga | Jan. 5, 2015 | 09:07AM EST
  23. Nasdaq, Russell 2000 Join New-High Party; GoPro Up Again

    IBD | Dec. 26, 2014 | 16:16PM EST
  24. Tesla Motors Up On Battery News; Stocks At Record

    IBD | Dec. 26, 2014 | 15:07PM EST
  25. Biotech Stocks Take A Beating, But Find Support

    IBD | Dec. 24, 2014 | 16:56PM EST
  26. Are There Any Winners Left In The Biotech Space?

    Benzinga | Dec. 24, 2014 | 13:01PM EST
  27. Indexes Turn Mixed On Data; Celgene Dives

    IBD | Dec. 23, 2014 | 10:43AM EST
  28. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD | Dec. 22, 2014 | 17:59PM EST
  29. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD | Dec. 22, 2014 | 10:34AM EST
  30. Meet 5 Big Tech Stocks Expected To See Profits Surge

    IBD | Dec. 16, 2014 | 19:46PM EST
  31. Amgen Just Crashed 50% In Premarket, Here's How It Looked

    Benzinga | Dec. 16, 2014 | 09:55AM EST
  32. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus | Dec. 15, 2014 | 16:57PM EST
  33. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD | Dec. 13, 2014 | 08:02AM EST
  34. How Can Drugmakers Handle New Pricing Pressures?

    IBD | Dec. 11, 2014 | 17:38PM EST
  35. Gilead Sciences Bucks Trend In Biotech Short Interest

    Benzinga | Dec. 11, 2014 | 12:06PM EST
  36. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  37. New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA For Advanced Melanoma

    Benzinga | Dec. 8, 2014 | 16:21PM EST
  38. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD | Dec. 4, 2014 | 16:47PM EST
  39. Large-Blend Funds Take The Lead For Year-To-Date Total Returns

    Benzinga | Dec. 2, 2014 | 17:52PM EST
  40. A Look At 3 Overbought ETFs

    Benzinga | Dec. 2, 2014 | 17:34PM EST
  41. Big CEOs Are Less Upbeat, But Plan To Hire More

    IBD | Dec. 2, 2014 | 13:28PM EST
  42. Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA ...

    GuruFocus | Dec. 2, 2014 | 11:03AM EST
  43. Meet 5 Top Drug Stocks That Are Bolting Past Market

    IBD | Dec. 2, 2014 | 08:02AM EST
  44. AMGEN

    IBD | Nov. 25, 2014 | 18:47PM EST
  45. #PreMarket Primer: Tuesday, November 25: Violent Protests In Ferguson Following Grand Jury Decision

    Benzinga | Nov. 25, 2014 | 08:16AM EST
  46. Dividend Aristocrats In Focus Part 45: AbbVie

    GuruFocus | Nov. 24, 2014 | 16:13PM EST
  47. Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer

    Benzinga | Nov. 24, 2014 | 09:16AM EST
  48. #PreMarket Primer: Wednesday, November 19: Burst Of Cold Creates Chaos In New York

    Benzinga | Nov. 19, 2014 | 07:50AM EST
  49. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  50. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
Trading Center